Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,672,040
-$13,299,038 QoQ
Shares Held
983,600
-49.7% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. JANX ranks #46 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $488,832,498 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
7,959,538 | $312,013,889 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
3,530,702 | $141,545,843 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
3,637,887 | $108,590,926 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $104,824,037 | |
| 6 | ARGX |
Argenx SE
|
136,900 | $99,971,225 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
15,219,994 | $80,513,768 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,475,403 | $71,114,424 |
All Filings in JANX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,672,040 | 983,600 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,971,078 | 1,954,426 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,163,484 | 1,766,100 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $27,957,930 | 1,210,300 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,481,282 | 758,566 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,613,623 | 758,566 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $57,176,653 | 1,258,566 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $124,824,994 | 2,979,828 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $160,974,570 | 4,275,553 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $35,601,356 | 3,317,927 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,444,704 | 3,317,927 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,667,901 | 2,836,386 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $34,320,270 | 2,836,386 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,355,203 | 2,836,386 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $38,404,666 | 2,836,386 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,632,273 | 2,836,386 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $40,673,775 | 2,836,386 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $55,961,895 | 2,836,386 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $74,977,929 | 3,466,386 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $86,486,330 | 3,466,386 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||